Coagulant Therapeutics
Cambridge, United States· Est. 2018
Developing medicines to treat acute bleeding through expertise and experience in both the coagulation cascade and biologics.
Private Company
Total funding raised: $40M
About
Developing medicines to treat acute bleeding through expertise and experience in both the coagulation cascade and biologics.
Biologics
Funding History
2Total raised:$40M
Series A$32MMay 15, 2022
Seed$8MSep 15, 2020